Matches in Wikidata for { <http://www.wikidata.org/entity/Q92125025> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q92125025 description "2019 թվականի հունվարի 11-ին հրատարակված գիտական հոդված" @default.
- Q92125025 description "article scientifique publié en 2019" @default.
- Q92125025 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q92125025 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92125025 description "scientific article published on 11 January 2019" @default.
- Q92125025 description "wetenschappelijk artikel" @default.
- Q92125025 description "наукова стаття, опублікована 11 січня 2019" @default.
- Q92125025 name "Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus" @default.
- Q92125025 name "Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus" @default.
- Q92125025 type Item @default.
- Q92125025 label "Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus" @default.
- Q92125025 label "Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus" @default.
- Q92125025 prefLabel "Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus" @default.
- Q92125025 prefLabel "Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus" @default.
- Q92125025 P1433 Q92125025-BF5F508F-9B77-47DB-95BC-6327AE38637A @default.
- Q92125025 P1476 Q92125025-47E0D52C-3D35-4382-96B9-9BC8A8343983 @default.
- Q92125025 P2093 Q92125025-87A607FE-FB6E-409D-84F5-5FC8BABF1C12 @default.
- Q92125025 P304 Q92125025-0BB3E426-4D64-461E-9247-500C6D62CD74 @default.
- Q92125025 P31 Q92125025-0D388972-A6C4-47B1-AD37-6EE089FBA0A9 @default.
- Q92125025 P356 Q92125025-6FDD4C06-6748-4D1E-A94B-725F479D1A7D @default.
- Q92125025 P433 Q92125025-679C25F9-E2DF-4721-BC67-18FBF3B060E7 @default.
- Q92125025 P478 Q92125025-FC345AE0-C12E-4575-9546-F5E0122F2D9D @default.
- Q92125025 P577 Q92125025-C254490F-919A-444B-97F9-7E4CEC666F33 @default.
- Q92125025 P698 Q92125025-97D51BD7-7B2B-4F60-88D7-05404492C21B @default.
- Q92125025 P921 Q92125025-CBA30967-A084-439A-9DA6-455905CF6460 @default.
- Q92125025 P356 J.JCJD.2019.01.001 @default.
- Q92125025 P698 30833122 @default.
- Q92125025 P1433 Q15816397 @default.
- Q92125025 P1476 "Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus" @default.
- Q92125025 P2093 "Tomoyuki Kawada" @default.
- Q92125025 P304 "4" @default.
- Q92125025 P31 Q13442814 @default.
- Q92125025 P356 "10.1016/J.JCJD.2019.01.001" @default.
- Q92125025 P433 "1" @default.
- Q92125025 P478 "44" @default.
- Q92125025 P577 "2019-01-11T00:00:00Z" @default.
- Q92125025 P698 "30833122" @default.
- Q92125025 P921 Q3025883 @default.